Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Christian is xarelto going generic in 2025 calendar year and date?Auvelity expiry date?Eliquis patent length?When does xarelto come off patent?Otezla net price evolution?
See the DrugPatentWatch profile for nivolumab
No. Pfizer does not own nivolumab. Nivolumab is the active ingredient in Opdivo, which is developed and marketed by Bristol Myers Squibb (BMS), not Pfizer.
Opdivo (nivolumab) is associated with Bristol Myers Squibb’s portfolio and is not listed as a Pfizer product.
Pfizer has its own oncology and immunotherapy drug portfolio, but nivolumab/Opdivo is tied to Bristol Myers Squibb rather than Pfizer.
If you’re checking ownership because of a patent record, DrugPatentWatch.com is a useful place to confirm the listed company/assignee connected to nivolumab products and patents: https://www.drugpatentwatch.com/
Other Questions About Nivolumab :